In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
486 News Items found
Boris Mueller, MD, Director, Radiation Oncology at MSK Bergen is seen standing in a hallway.
Breast Cancer and Tattoo-Less Radiation at MSK

Learn how people with early stage breast cancer can receive radiation therapy without the need for tattoos at Memorial Sloan Kettering Cancer Center.
Rachel Samuels Rand (l) with her husband, Brendan Rand.
3-D Nipple Tattoos After Breast Cancer Surgery: An MSK Specialty

Learn how specialists at Memorial Sloan Kettering tattoo highly realistic nipples and areolas on people who have had them removed during surgery for breast cancer.
Man meets with a doctor
In the News
FDA Recommends Including Men in Breast Cancer Trials

The recommendation comes in the form of draft guidelines open for public comment until October 2019.
Selfie of Stephanie Soto-Vega with her husband Eduardo and daughter Luna
She Couldn’t Afford Metastatic Breast Cancer Treatment: How MSK Helped

Learn what can be done for patients like Stephanie Soto-Vega who confront financial hardships caused by cancer.
Memorial Sloan Kettering Ralph Lauren Center nurse Jasmine Gibson, breast cancer patient Maria Tucker, and nurse Margaret Bediones
Expert Breast Cancer Treatment in Harlem at MSK’s Ralph Lauren Center

See how experts at Memorial Sloan Kettering Cancer Center's Ralph Lauren Center cared for Maria close to home.
Kate Delp standing on the beach, smiling and holding a yoga mat
Finding
Why More People With Breast Cancer Are Choosing Lumpectomy Over Mastectomy: Kate’s Story

An MSK study found a rise in lumpectomies and a decline in mastectomies — reversing a trend that experts say was leading to the overtreatment of breast cancer.
Head shot of doctor with glasses, white shirt, and blue tie in his lab.
In the Clinic
Drug Reduces Recurrence Risk in Subset of Women with Breast Cancer

A drug was shown to improve outcomes in women with HER2-positive early breast cancer when added to standard therapy.
Dr. Shanu Modi speaks with a patient
In the Clinic
FDA Approves Trastuzumab Deruxtecan (T-DXd) for Early-Stage HER2-Positive Breast Cancer

The FDA has approved trastuzumab deruxtecan (T-DXd, Enhertu) for treating early-stage, HER2-positive breast cancer based in part on clinical research led by MSK breast medical oncologist Shanu Modi, MD.
Reilly Starr with her husband and their son on her husband's shoulders
Always by Your Side: How MSK Helps People Facing Metastatic Breast Cancer

Learn how people facing metastatic breast cancer help each other in support groups at Memorial Sloan Kettering.
Medical oncologist Mark Robson
In the Clinic
Phase III Trial of Targeted Drug Shows Promise in Treating Metastatic Breast Cancer

Investigators found that olaparib extended progression-free survival by an average of three months in women with advanced breast cancer.